The Valley Desk

Clinical trial reportCirculation. Heart failurePublished

Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial

Read the publication ↗ Open access copy ↗

Regional connection

Listed An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Clinical trial report
Venue
Circulation. Heart failure
Published
Subject terms
Humans; Hypertrophy, Left Ventricular; Cardiomyopathy, Hypertrophic; Disease Progression; Angiotensin II Type 1 Receptor Blockers; Treatment Outcome; Double-Blind Method; Proteomics; Ventricular Remodeling; Phenotype; Adult; Aged
PubMed ID
40340372
PubMed Central ID
PMC12173761
Added to directory
Source checked

Report a correction or request removal